UCAL

₹170 4.9 | 3%

WEBSITE BSE:500464 NSE : UCAL 10 May, 16:01

Market Cap ₹376 Cr.

Stock P/E -27.3

P/B 1

Current Price ₹170

Book Value ₹ 174.2

Face Value 10

52W High ₹195.5

Dividend Yield 1.18%

52W Low ₹ 118.4

Edit Ratio

UCAL Research see more...

Overview Inc. Year: 1985Industry: Auto Ancillary

Ucal Fuel Systems Ltd gives fuel management structures for the automobile area in India. The company gives multi factor fuel injection components, inclusive of throttle frame assemblies, fuel rail assemblies, high-pressure fuel filters, and pressure regulators and pulsation dampers; carburetors; and emission control products, such as positive crankcase ventilation valves and intake manifolds for four-wheelers. It additionally provides secondary air valves; and EMS gadget merchandise that consist of throttle bodies, fuel pumps, air compressors, and fuel rail assemblies for 2/3-wheelers. In addition, the enterprise offers digital solenoid fuel pumps for gensets; oil, vacuum, and water pump assemblies, in addition to fuel pumps along with piston-pushed, high-pressure impeller pushed, and electronic solenoid; high pressure die casting products, which include air consumption and steerage systems, turbochargers, and emission control and different products; and precision machined products, together with shaft second clutches, housing spring and frame injectors, and transmission and rocker arm shafts. It also exports its products. Ucal Fuel Systems Ltd was founded in 1985 and is established in Chennai, India.

UCAL Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

UCAL Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	221	209	171	193	245	199	186	184	174	187
Other Income	2	1	27	1	3	2	3	2	2	4
Total Income	222	210	198	195	247	202	188	187	176	191
Total Expenditure	193	191	169	177	221	186	182	176	159	176
Operating Profit	30	19	29	17	27	16	7	10	17	16
Interest	7	6	4	5	6	6	5	6	7	5
Depreciation	10	10	12	9	10	9	10	9	10	10
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	13	4	12	2	11	1	-8	-4	-1	1
Provision for Tax	3	1	-0	3	4	1	-1	0	1	2
Profit After Tax	10	3	13	-0	7	0	-7	-5	-1	-1
Adjustments	0	-0	0	0	0	0	0	0	0	0
Profit After Adjustments	10	3	13	-0	7	0	-7	-5	-1	-1
Adjusted Earnings Per Share	4.5	1.3	5.7	-0.1	3.4	0.1	-3	-2.2	-0.7	-0.4

UCAL Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	654	644	738	724	791	820	870	732	687	782	823	731
Other Income	8	11	10	11	11	7	6	12	13	31	9	11
Total Income	662	655	748	735	802	827	876	744	700	813	832	742
Total Expenditure	586	581	650	651	689	697	745	643	620	710	766	693
Operating Profit	76	74	98	84	113	130	131	101	79	103	67	50
Interest	38	36	31	27	28	26	27	27	28	23	22	23
Depreciation	28	28	34	33	34	30	30	40	40	41	38	39
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	10	10	33	23	51	74	73	35	11	39	6	-12
Provision for Tax	4	3	9	8	15	-27	27	14	-18	4	6	2
Profit After Tax	6	7	25	16	36	101	46	21	29	35	1	-14
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	6	7	25	16	36	101	46	21	29	35	1	-14
Adjusted Earnings Per Share	2.7	3.1	11.1	7	16.2	45.8	20.7	9.6	13.1	15.8	0.4	-6.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	5%	4%	0%	2%
Operating Profit CAGR	-35%	-13%	-12%	-1%
PAT CAGR	-97%	-64%	-60%	-16%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	39%	5%	2%	13%
ROE Average	0%	6%	8%	19%
ROCE Average	5%	7%	10%	13%

UCAL Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	59	56	66	31	211	298	322	331	358	392	393
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	207	170	110	79	95	74	69	68	114	77	62
Other Non-Current Liabilities	-3	0	-7	20	22	-11	-6	35	2	-5	-12
Total Current Liabilities	311	320	352	365	315	329	343	327	348	277	304
Total Liabilities	573	545	521	496	643	690	728	762	822	741	747
Fixed Assets	315	292	271	255	373	385	406	495	471	460	436
Other Non-Current Assets	19	19	15	13	54	70	74	69	52	56	79
Total Current Assets	238	234	235	228	215	235	249	197	299	225	233
Total Assets	573	545	521	496	643	690	728	762	822	741	747

UCAL Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	6	6	3	3	-78	-75	-91	-54	-46	-16	-45
Cash Flow from Operating Activities	64	76	92	81	98	78	130	134	10	81	78
Cash Flow from Investing Activities	-10	-5	-12	-14	-19	-45	-44	-72	-9	-29	-33
Cash Flow from Financing Activities	-54	-74	-80	-67	-71	-49	-48	-65	31	-83	-9
Net Cash Inflow / Outflow	-0	-4	-0	-0	8	-15	38	-3	32	-32	36
Closing Cash & Cash Equivalent	6	3	3	3	-75	-91	-54	-46	-16	-45	-4

UCAL Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	2.71	3.1	11.1	7.04	16.22	45.77	20.72	9.56	13.05	15.78	0.39
CEPS(Rs)	15.19	15.77	26.26	22.19	31.45	59.18	34.48	27.43	31.34	34.45	17.58
DPS(Rs)	1	1	2	3.5	5	10	9	0	2	2	2
Book NAV/Share(Rs)	25.95	25.13	29.85	14.2	95.24	134.95	145.72	149.67	162.07	177.05	177.87
Core EBITDA Margin(%)	9.31	8.82	10.89	9.17	11.69	14.46	14.3	12.16	9.69	9.3	6.98
EBIT Margin(%)	6.66	6.43	8.02	6.34	9.1	11.77	11.52	8.44	5.67	7.94	3.46
Pre Tax Margin(%)	1.44	1.4	4.13	2.92	5.87	8.7	8.4	4.78	1.6	4.99	0.78
PAT Margin (%)	0.83	0.96	3.04	1.95	4.1	11.9	5.27	2.89	4.2	4.46	0.1
Cash Profit Margin (%)	4.64	4.92	7.19	6.15	7.96	15.39	8.77	8.29	10.09	9.74	4.72
ROA(%)	1.02	1.22	4.6	3.06	6.3	15.19	6.46	2.84	3.64	4.46	0.11
ROE(%)	10.51	12.12	40.38	31.97	29.64	39.77	14.76	6.48	8.37	9.3	0.22
ROCE(%)	11.12	10.75	16.29	14.27	20.1	19.55	18.04	11.18	6.58	9.97	4.7
Receivable days	56.82	59.77	51.61	48.89	45.45	50.84	53.92	54.09	56.94	53.66	47.86
Inventory Days	37.18	36.78	33.18	35.36	32.01	34.37	36.41	44.83	50.11	47.52	45.25
Payable days	373.38	325.67	341.26	376.6	125.29	128.22	126.26	169.04	144.78	97.23	77.82
PER(x)	18.16	15.54	9.94	14.78	13.4	5.13	7.82	7.58	10.75	7.1	281.06
Price/Book(x)	1.89	1.91	3.7	7.33	2.28	1.74	1.11	0.48	0.87	0.63	0.61
Dividend Yield(%)	2.03	2.08	1.81	3.36	2.3	4.26	5.56	0	1.43	1.79	1.85
EV/Net Sales(x)	0.74	0.71	0.76	0.72	0.92	0.95	0.67	0.51	0.8	0.6	0.54
EV/Core EBITDA(x)	6.33	6.25	5.68	6.2	6.45	5.98	4.48	3.72	6.95	4.53	6.66
Net Sales Growth(%)	-3.93	-1.49	14.58	-1.91	9.32	3.7	6.02	-15.9	-6.12	13.92	5.2
EBIT Growth(%)	-29.11	-5.5	42.04	-21.94	57.27	25.84	0.14	-38.41	-36.9	59.55	-54.11
PAT Growth(%)	-74.98	14.4	258.61	-36.58	130.32	182.25	-54.74	-53.83	36.45	20.88	-97.56
EPS Growth(%)	-74.98	14.4	258.61	-36.58	130.32	182.25	-54.74	-53.83	36.45	20.88	-97.56
Debt/Equity(x)	6.59	6.42	4.8	9.36	1.21	0.87	0.71	0.67	0.76	0.57	0.52
Current Ratio(x)	0.77	0.73	0.67	0.62	0.68	0.71	0.73	0.6	0.86	0.81	0.77
Quick Ratio(x)	0.53	0.51	0.45	0.41	0.44	0.46	0.47	0.32	0.58	0.43	0.44
Interest Cover(x)	1.28	1.28	2.06	1.86	2.82	3.83	3.69	2.31	1.39	2.69	1.29
Total Debt/Mcap(x)	3.48	3.35	1.3	1.28	0.53	0.5	0.64	1.37	0.88	0.9	0.86

UCAL Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	70.33	70.33	70.33	70.33	70.28	70.28	70.28	70.28	70.28	70.28
FII	0.28	0.19	0.02	0.16	0	0	0	0	0	0
DII	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Public	29.38	29.47	29.64	29.5	29.71	29.71	29.71	29.71	29.71	29.71
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	1.56	1.56	1.56	1.56	1.55	1.55	1.55	1.55	1.55	1.55
FII	0.01	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.65	0.65	0.66	0.65	0.66	0.66	0.66	0.66	0.66	0.66
Others	0	0	0	0	0	0	0	0	0	0
Total	2.21	2.21	2.21	2.21	2.21	2.21	2.21	2.21	2.21	2.21

Pros

Debtor days have improved from 97.23 to 77.82days.
Company has reduced debt.

Cons

Company has a low return on equity of 6% over the last 3 years.
The company has delivered a poor profit growth of -60% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.